Side effects such as cutaneous vasculitis, which occur during prolonged lev
amisole treatment, may discourage the utilization of the drug in relapsing
nephrotic syndrome. We describe a child who developed disseminated vasculit
is during prolonged treatment with levamisole. The acute phase was characte
rized by hepatosplenomegaly, hemolytic anemia, IgM anticardiolipin and p-an
tineutrophil cytoplasmic antibodies. One month after withdrawal of therapy
all symptoms had disappeared and tests normalized. This case report, togeth
er with other reports on cutaneous vasculitis, suggest caution and close mo
nitoring during prolonged levamisole therapy.